The first Finch Therapeutics Group trade was made in Q1 2021.
Since then Seth Klarman bought shares one more times and sold shares on five occasions. The investor completely sold their stake between Q2 2023 and Q1 2024.
Avg closing price
Price range
Sold -67.3 Thousand shares
Q1 2024
Avg closing price
$2.79
Price range
$2.31
-
$3.82
Sold 0.0% shares (-4 shares)
Q2 2023
Avg closing price
$2.21
Price range
$0.27
-
$11.50
Increased shares by 98.1% (+33.3 Thousand shares)
Q1 2023